Thomas Hildmann
7Patents
2h-index
19Co-inventors
44Inventor score
Filing activity: Apr 17, 2006 → Jun 26, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7749702B2 | Methods and nucleic acids for the analyses of cellular proliferative disorders | Chemistry; Metallurgy | 24 | Active |
| US8900829B2 | Methods and nucleic acids for analyses of cellular proliferative disorders | Chemistry; Metallurgy | 8 | Active |
| US9695478B2 | Methods and nucleic acids for the analyses of cellular proliferative disorders | Chemistry; Metallurgy | 1 | Active |
| US10385402B2 | Methods and nucleic acids for analyses of cellular proliferative disorders | Chemistry; Metallurgy | 0 | Active |
| US11186879B2 | Methods and nucleic acids for analyses of cellular proliferative disorders | Chemistry; Metallurgy | 0 | Active |
| US10053735B2 | Markers for the prediction of outcome of anthracycline treatment | Chemistry; Metallurgy | 0 | Active |
| US7951563B2 | Methods and nucleic acids for analysis of cellular proliferative disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.